ceres inc (CERE:NASDAQ GM)

Executive Profile*

Background*

Ms. Cheryl P. Morley served as Senior Vice President of Corporate Strategy at Monsanto Company from June 18, 2003 to October 23, 2009. Ms. Morley oversaw mergers, acquisitions and Monsanto's venture fund. Ms. Morley served as President of Animal Agricultural Group of Monsanto Company from August 2000 to June 2003. Ms. Morley served as President of Animal Agricultural Group-Pharmacia Corporation from 1997 to 2000. She led the marketing and business development efforts ... of Monsanto's NutraSweet product. She served a number of positions that involve strategic planning, commercial development and financial analysis at G.D. Searle and Nabisco Brands. Previously, she served as the Strategic Planning and Commercial Development Lead in the Animal Ag business of Monsanto. She also served in the New Business Lead in Plant Biotechnology. Ms. Morley served as a Certified Public Accountant at Ernst & Young. She has been Chairman of Strategic Advisory Board at Joule Biotechnologies, Inc. (alternate name Joule Unlimited, Inc.) since January 2010. Ms. Morley served as Chairman of Nidus Center for Scientific Enterprise from September 2003 to October 2010. She has been a Director of Ceres, Inc. since August 2011. Ms. Morley has been a Board Member of Fleming Pharmaceuticals since March 2010. She has been a Member of the Business Development Advisory Board of Essentient, Inc. since November 2010. She has been a Director of Mercy Health Plans, Inc. since June 20011 and Missouri Botanical Gardens since June 2006. she serves on the Board of St. John's Mercy Hospital System. She serves as a Director of Nidus Center for Scientific Enterprise. She serves as a Director of the Animal Health Institute. She serves on Advisory Board positions for St. Joseph's Hospital/SSM Healthcare and St. Louis University's Business Women in Leadership Program, and on the Advisory Council of St. Louis OASIS (an organization that works to enrich the lives of older adults). Ms. Morley served as a Director of Endo Pharmaceuticals Solutions Inc. (aka Indevus Pharmaceuticals Inc.) from June 9, 2003 to February 23, 2009 and served as its Presiding Director from December 12, 2004 to June 2008. She is active in a number of organizations. Ms. Morley was awarded the YWCA Leadership Award in 1998, and in 1988 was named a Fellow by Leadership Greater Chicago, an organization that identifies and develops potential community leaders. She holds a B.S.B.A. from the University of Arizona and is a Certified Public Accountant.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CERE:US	$2.15 USD	-0.01

COMPETITOR COMPENSATION